Selected research
Industry Research
Steroid APIs Industry Research Report 2026
Market perspective
The global Steroid APIs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Steroid APIs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Steroid APIs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Steroid APIs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Steroid APIs include Zhejiang Xianju Pharmaceutical, Tianjin Tianyao Pharmaceutical, Sanofi, MSD, Tianjin Jinjin Pharmaceutical, Pfizer, Henan LIHUA Pharmaceutical, Bayer and Steroid, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Steroid APIs market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Steroid APIs Market by Company
Zhejiang Xianju Pharmaceutical
Tianjin Tianyao Pharmaceutical
Sanofi
MSD
Tianjin Jinjin Pharmaceutical
Pfizer
Henan LIHUA Pharmaceutical
Bayer
Steroid
Steroid APIs Segment by Type
Estrogens
Anabolics
Corticosteroids
Progestinics
Others
Steroid APIs Segment by Application
Industrial
Laboratory
Steroid APIs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Steroid APIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Steroid APIs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Steroid APIs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Steroid APIs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Steroid APIs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Steroid APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Estrogens
- Anabolics
- Corticosteroids
- Progestinics
- Others
Applications
- Industrial
- Laboratory
Companies covered
- Zhejiang Xianju Pharmaceutical
- Tianjin Tianyao Pharmaceutical
- Sanofi
- MSD
- Tianjin Jinjin Pharmaceutical
- Pfizer
- Henan LIHUA Pharmaceutical
- Bayer
- Steroid
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Steroid APIs Market Size (2021-2032)
- 2.2.2 Global Steroid APIs Sales (2021-2032)
- 2.2.3 Global Steroid APIs Market Average Price (2021-2032)
- 2.3 Steroid APIs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Estrogens
- 2.3.3 Anabolics
- 2.3.4 Corticosteroids
- 2.3.5 Progestinics
- 2.3.6 Others
- 2.4 Steroid APIs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Industrial
- 2.4.3 Laboratory
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Steroid APIs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Steroid APIs Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Steroid APIs Revenue of Manufacturers (2021-2026)
- 3.4 Global Steroid APIs Average Price by Manufacturers (2021-2026)
- 3.5 Global Steroid APIs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Steroid APIs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Steroid APIs, Product Type & Application
- 3.8 Global Manufacturers of Steroid APIs, Established Date
- 3.9 Global Steroid APIs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Xianju Pharmaceutical
- 4.1.1 Zhejiang Xianju Pharmaceutical Company Information
- 4.1.2 Zhejiang Xianju Pharmaceutical Business Overview
- 4.1.3 Zhejiang Xianju Pharmaceutical Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Xianju Pharmaceutical Steroid APIs Product Portfolio
- 4.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
- 4.2 Tianjin Tianyao Pharmaceutical
- 4.2.1 Tianjin Tianyao Pharmaceutical Company Information
- 4.2.2 Tianjin Tianyao Pharmaceutical Business Overview
- 4.2.3 Tianjin Tianyao Pharmaceutical Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Tianjin Tianyao Pharmaceutical Steroid APIs Product Portfolio
- 4.2.5 Tianjin Tianyao Pharmaceutical Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Steroid APIs Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 MSD
- 4.4.1 MSD Company Information
- 4.4.2 MSD Business Overview
- 4.4.3 MSD Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 MSD Steroid APIs Product Portfolio
- 4.4.5 MSD Recent Developments
- 4.5 Tianjin Jinjin Pharmaceutical
- 4.5.1 Tianjin Jinjin Pharmaceutical Company Information
- 4.5.2 Tianjin Jinjin Pharmaceutical Business Overview
- 4.5.3 Tianjin Jinjin Pharmaceutical Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Tianjin Jinjin Pharmaceutical Steroid APIs Product Portfolio
- 4.5.5 Tianjin Jinjin Pharmaceutical Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Steroid APIs Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Henan LIHUA Pharmaceutical
- 4.7.1 Henan LIHUA Pharmaceutical Company Information
- 4.7.2 Henan LIHUA Pharmaceutical Business Overview
- 4.7.3 Henan LIHUA Pharmaceutical Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Henan LIHUA Pharmaceutical Steroid APIs Product Portfolio
- 4.7.5 Henan LIHUA Pharmaceutical Recent Developments
- 4.8 Bayer
- 4.8.1 Bayer Company Information
- 4.8.2 Bayer Business Overview
- 4.8.3 Bayer Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bayer Steroid APIs Product Portfolio
- 4.8.5 Bayer Recent Developments
- 4.9 Steroid
- 4.9.1 Steroid Company Information
- 4.9.2 Steroid Business Overview
- 4.9.3 Steroid Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Steroid Steroid APIs Product Portfolio
- 4.9.5 Steroid Recent Developments
5 Global Steroid APIs Market Scenario by Region
- 5.1 Global Steroid APIs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Steroid APIs Sales by Region: 2021-2032
- 5.2.1 Global Steroid APIs Sales by Region: 2021-2026
- 5.2.2 Global Steroid APIs Sales by Region: 2027-2032
- 5.3 Global Steroid APIs Revenue by Region: 2021-2032
- 5.3.1 Global Steroid APIs Revenue by Region: 2021-2026
- 5.3.2 Global Steroid APIs Revenue by Region: 2027-2032
- 5.4 North America Steroid APIs Market Facts & Figures by Country
- 5.4.1 North America Steroid APIs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Steroid APIs Sales by Country (2021-2032)
- 5.4.3 North America Steroid APIs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Steroid APIs Market Facts & Figures by Country
- 5.5.1 Europe Steroid APIs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Steroid APIs Sales by Country (2021-2032)
- 5.5.3 Europe Steroid APIs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Steroid APIs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Steroid APIs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Steroid APIs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Steroid APIs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Steroid APIs Market Facts & Figures by Country
- 5.7.1 South America Steroid APIs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Steroid APIs Sales by Country (2021-2032)
- 5.7.3 South America Steroid APIs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Steroid APIs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Steroid APIs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Steroid APIs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Steroid APIs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Steroid APIs Sales by Type (2021-2032)
- 6.1.1 Global Steroid APIs Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Steroid APIs Sales Market Share by Type (2021-2032)
- 6.2 Global Steroid APIs Revenue by Type (2021-2032)
- 6.2.1 Global Steroid APIs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Steroid APIs Revenue Market Share by Type (2021-2032)
- 6.3 Global Steroid APIs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Steroid APIs Sales by Application (2021-2032)
- 7.1.1 Global Steroid APIs Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Steroid APIs Sales Market Share by Application (2021-2032)
- 7.2 Global Steroid APIs Revenue by Application (2021-2032)
- 7.2.1 Global Steroid APIs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Steroid APIs Revenue Market Share by Application (2021-2032)
- 7.3 Global Steroid APIs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Steroid APIs Value Chain Analysis
- 8.1.1 Steroid APIs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Steroid APIs Production Mode & Process
- 8.2 Steroid APIs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Steroid APIs Distributors
- 8.2.3 Steroid APIs Customers
9 Global Steroid APIs Analyzing Market Dynamics
- 9.1 Steroid APIs Industry Trends
- 9.2 Steroid APIs Industry Drivers
- 9.3 Steroid APIs Industry Opportunities and Challenges
- 9.4 Steroid APIs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst